Alcon, Inc.

Alcon Manufacturing, Ltd.

Alcon Pharmaceuticals Ltd.

Robert L Abshire

John M Yanni

Gerald D Cagle

David W Stroman

Linda L Clark

Celeste H McLean

David W Stromann

Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues.

Compositions containing moxifloxacin for treating otic infections

Method of treating otic infections with moxifloxacin compositions

Method of treating ophthalmic infections with moxifloxacin compositions

Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues. The compositions and methods of the invention are particularly useful in the treatment of acute otitis externa infections and ophthalmic infections attributable to one or both of two newly identified Microbacterium species, and

Methods for treating otic and ophthalmic infections

Ophthalmic antibiotic compositions containing moxifloxacin

Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues. The compositions and methods of the invention are particularly useful in the treatment of acute otitis externa infections attributable to one or both of two newly identified Microbacterium species, and

Compositions and methods for treating otic, ophthalmic and nasal infections

Compositions and methods for treating ophthalmic and otic infections

Methods of treating or preventing ophthalmic, otic, and nasal infections and attendant inflammation are described. The methods utilize ophthalmic, otic, and nasal compositions containing a new class of antibiotics (e.g. trovafloxacin). The compositions also contain one or more anti-inflammatory agents (e.g. dexamethasone). The compositions are utilized to treat ophthalmic, otic, and nasal conditions by topically applying the compositions to the affected tissues.

Methods of treating ophthalmic, otic and nasal infections and attendant inflammation

Growing community of inventors

Fort Worth, TX, United States of America

Robert L Abshire